ArticleStem cell research & therapy2025
Extracellular vesicles derived from clonal mesenchymal stromal cells preconditioned by indirect hypoxia modulate immune responses in diabetic mice more effectively than directly preconditioned vesicles.
Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundMesenchymal stem/stromal cells (MSCs) or MSC-derived extracellular vesicles (MSC-EVs) are considered potential modulators of the immune system in type 1 diabetes (T1D) therapy. On the other hand, preconditioning MSCs with inflammatory agents is a promising strategy to improve the therapeutic effects of these cells. Therefore, we performed various direct preconditioning regimens (IFN-γ, poly(I: C), LPS, and hypoxia) on clonal MSCs (cMSCs), and for indirect preconditioning regimens, the same regimens were applied to peripheral blood mononuclear cells (PBMCs). PBMC-derived concentrated conditioned media (CCM) was transferred into cMSC cultures to mimic in vivo conditions to obtain cMSC-EVs with better immunomodulatory effects and then selected hypoxia-induced cMSC-EVs and their source cells to determine their influence on immune responses in multiple low-dose/Streptozotocin (MLD/STZ)-induced mouse model.
methodsDirect preconditioning regimens include four groups: IFN-γ (50 ng/ml), poly(I: C) (42.22 µg/ml), LPS (1 µg/ml), and hypoxia (1% oxygen). For indirect preconditioning, these regimens were applied to PBMCs, and PBMC-derived CCM was added to cMSC cultures. The resulting cMSC-CCM was assessed for the expression of anti-inflammatory, pro-inflammatory, and regenerative factors and its ability to inhibit lymphocyte proliferation. The isolated EVs from the most effective direct and indirect preconditioned cMSC-CCM groups and their source cells were transplanted in MLD/STZ-induced mouse models of T1D and followed for 73 days.
resultsIn vitro characterization revealed that direct and indirect hypoxia preconditioning were the most effective groups among the different preconditioning regimens. Therefore, four treatment groups, including direct hypoxia-induced cMSC-EVs (dH-MSC-EVs), indirect hypoxia-induced MSC-derived EVs (iH-MSC-EVs), and their cell sources (dH-MSCs and iH-MSCs), were selected for EV isolation and animal studies. The in vivo study revealed that the fasting blood glucose (FBG) trend decreased in the four treatment groups compared with the sham group. However, the effects of direct/indirect hypoxia on cMSC-EVs were associated with an increase in the levels of anti-inflammatory cytokines (IL-4 and IL-10) in the serum of the MLD/STZ-induced mouse models compared with their parental cell counterparts. Indeed, iH-MSC-EVs attenuate immune responses in MLD/STZ-induced mouse models. Furthermore, compared with their source cells and dH-MSC-EVs, iH-MSC-EVs significantly reduced the levels of proinflammatory cytokines (TNF-α and IL-6) in the serum of the MLD/STZ-induced mouse models.
conclusionOur results showed the effectiveness of direct/indirect hypoxia preconditioning for cMSCs to modulate immune responses in the MLD/STZ-induced mice model. This study demonstrated that the immunomodulatory potential of iH-MSC-EVs is significantly greater than that of dH-MSC-EVs and their source cells. Our results suggest iH-MSC-EVs, could be a potential option for modulating the immune response in T1D.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.